The Patent Finder

Shaare Zedek Scientific Ltd.

7 patents currently held · Updated Nov 16, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Oct 2036
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 11, 2027
    The maintenance fee for Device and method for perfusing a subject's heart via the coronary sinus (US 11,696,980) comes due Jan 11, 2027. Unpaid by Jul 12, 2027, it lapses early.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Liposome composition co-encapsulating doxorubicin and a prodrug of mitomycin C (US 10,617,672) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 18, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

PatentTitleStatus Expires Confidence
US 10,617,672Liposome composition co-encapsulating doxorubicin and a prodrug of mitomycin C
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,716,655Neck lift sling
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,219,707Implantable renal replacement therapy device
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,161,364Surgical device for implant removal
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,171,746Liposome Composition Comprising Liposomal Prodrug of Mitomycin C and Method of Manufacture
In force
 · High confidence
In forceHigh confidence
US 11,696,980Device and method for perfusing a subject's heart via the coronary sinus
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,491,297Implantable renal replacement therapy device
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 7: 2 patents in force now held by others · 1 lapsed for an unpaid fee. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

5 pending · 6 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited